Research
Testing BRCA1 variants reveals differences in breast cancer risk
The Brief
- Researchers at the Francis Crick Institute tested thousands of possible BRCA1 mutations in mammary gland cells.
- The work aims to identify which BRCA1 genetic variants confer a high risk of breast cancer.
- The source reports the findings may help improve how genetic test results are interpreted.
Why it matters
Many BRCA1 variants are found in genetic testing without a clear risk meaning; systematic functional testing could help clinicians and patients interpret results more accurately.
Who’s affected
- clinical geneticists and genetic counsellors
- people undergoing BRCA1 genetic testing
- breast cancer researchers
- #brca1
- #breast cancer
- #genetics
- #variant interpretation
- #cancer risk
Researchers at the Francis Crick Institute have tested thousands of possible BRCA1 mutations in mammary gland cells to shed light on which genetic variants confer a high risk of developing breast cancer. Research like this holds potential to improve how genetic results are…
Timeline
Medical Xpress - latest medical and health news stories
Testing BRCA1 variants reveals differences in breast cancer risk
Medical Xpress reports on the Francis Crick Institute BRCA1 variant testing research